Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Announcements
Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Anelia Horvath
Five Questions with Anelia Horvath, PhD, M.Sc.
For Anelia Horvath, the big picture comprises tiny particles. She studies genetic variants from single-cell RNA-sequencing data, and these little pieces of the puzzle are leading to important discoveries and answering huge questions.
Sora Ely, MD
Sora Ely, MD, Named Co-Chair of DC Cancer Coalition
The GW Cancer Center is proud to announce that thoracic surgeon Sora Ely, MD, has been appointed as the Co-Chair of the DC Cancer Coalition, a pivotal organization dedicated to reducing the cancer burden in the District of Columbia.
Maria Vicera
Five Questions with Maria Vicera, Clinical Oncology Nurse
Maria Vicera is a follower of dreams. Though she didn’t pursue the career she initially thought she would, she’s found fulfillment and purpose as a remote clinical oncology nurse at the GW Cancer Center.